Who are we?
The Health Data Lab (HDL) at the Federal Institute for Drugs and Medical Devices (BfArM) aims to promote medical research in order to improve healthcare for citizens. Research generates new insights that ultimately help to further develop medical treatments more quickly and in a more targeted manner.
The HDL is an evolution of the former data processing unit, which was based at the former German Institute for Medical Documentation and Information (DIMDI) since 2013 and enabled the analysis of claims data for research purposes. In 2019, DIMDI was dissolved, and with the enactment of the Digital Healthcare Act, the establishment of the HDL was initiated. The HDL takes over all tasks of the former data processing unit and fully replaces it. The legislator has enacted the Data Transparency Regulation (DaTraV) and the Health Data Use Act (GDNG) to specify the legal framework. Although the HDL is located at BfArM, it operates independently and autonomously. The center is currently still being established and will begin accepting the first applications for data use starting in early 2025.
New HDL currently being established
The new Health Data Lab is currently in the process of being established which will take place in phases. Unfortunately, no applications can be submitted at this time. First, the legal, technical personnel and organisational measures of the new HDL must be defined and implemented. It is expected that applications can be submitted online in the first half of 2025.